← All trials
NCT01587508
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2013
- Primary completion
- May 1, 2013
- Completion date
- May 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- —
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Eurofarma Laboratorios S.A.Lead sponsor
- Federal University of Juiz de ForaOverall official - principal investigator
- Faculdade de Medicina do ABCOverall official - principal investigator
- Santa Casa de Misericórdia de Belo HorizonteOverall official - principal investigator
- Santa Casa de VotuporangaOverall official - principal investigator
- Hospital Santa Marcelina, Sao Paulo, BrasilOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.